A PhD graduate of Rockefeller University, Jef Boeke is a professor and director at the NYU Langone Medical Center, where he oversees the Institute for Systems Genetics. Jef Boeke is also the founder and a scientific advisory board member of CDI Labs, Inc, which together with Johns Hopkins University School of Medicine received a major grant from the National Institute of Health (NIH) to isolate, develop and characterize human transcription-specific monoclonal antibodies.
With roots reaching back to 1887, when the Marine Hospital Service launched what would become the United States Public Health Service, the National Institute of Health is designed to address the most pressing research needs of the day. Comprised of 27 centers and institutes, the NIH oversees 10 different medical research initiatives that focus funding and support on areas including women in biomedical careers and environmental influences on children’s health, among others. Throughout its history, the NIH has provided funding for hundreds of scientists, including the recipients of 87 Nobel Prizes.
In 2015 alone, the National Institute of Health awarded more than $20 billion to universities and researchers across the world. Available for career development purposes, research projects, and other programs, the NIH grant process takes approximately 10 months to complete. After submitting an application through Grants.gov, the organization assigns it to the relevant NIH institute and review group. From the third through eighth months of the process, the application is assigned an impact score after two levels of review. Finally, approved applications go through a grant negotiation period and the applicants are notified of the outcomes.